| Enriched cancer pathway | Genes under regulation | P value |
|---|
| Hippo signaling pathway |
10 genes: AMOT, WWTR1, DLG2, TEAD1, CTGF, FGF1, GDF6, BMPR1B, AXIN2, ACTB
|
1.452e-05 |
| Calcium signaling pathway |
8 genes: CHRM3, PLCB1, GNAQ, ATP2B4, PDE1C, PTGFR, RYR2, CAMK2A
|
0.001199 |
| Melanogenesis |
6 genes: PLCB1, GNAO1, GNAQ, KIT, KITLG, CAMK2A
|
0.001236 |
| Gastric acid secretion |
5 genes: CHRM3, PLCB1, GNAQ, ACTB, CAMK2A
|
0.001789 |
| PI3K AKT signaling pathway |
11 genes: FGF1, FGF9, CSF1, KITLG, EFNA2, INSR, KIT, COL4A1, LAMC1, RELN, FOXO3
|
0.003041 |
| Pancreatic secretion |
5 genes: CHRM3, PLCB1, GNAQ, ATP2B4, RYR2
|
0.006821 |
| Ras signaling pathway |
8 genes: FGF1, FGF9, CSF1, KITLG, EFNA2, INSR, KIT, RASGRP1
|
0.006943 |
| Adherens junction |
4 genes: SORBS1, FER, INSR, ACTB
|
0.01074 |
| Neurotrophin signaling pathway |
5 genes: SH2B3, IRAK3, FOXO3, NTRK3, CAMK2A
|
0.01717 |
| Notch signaling pathway |
3 genes: MFNG, NOTCH2, KAT2B
|
0.01776 |
| ECM.receptor interaction |
4 genes: COL4A1, LAMC1, RELN, SV2B
|
0.01794 |
| Salivary secretion |
4 genes: CHRM3, PLCB1, GNAQ, ATP2B4
|
0.02087 |
| Glycosaminoglycan biosynthesis . chondroitin sulfate |
2 genes: CHST11, XYLT1
|
0.02721 |
| Vascular smooth muscle contraction |
4 genes: CALCRL, MRVI1, PLCB1, GNAQ
|
0.04808 |
| Long.term potentiation |
3 genes: PLCB1, GNAQ, CAMK2A
|
0.04937 |
| Long.term depression |
3 genes: PLCB1, GNAO1, GNAQ
|
0.04937 |